Literature DB >> 18197377

Prognosis of mild cognitive impairment syndrome: data from a two-year clinical follow-up study.

S I Gavrilova1, Ya B Fedorova, I F Roshchina, G I Korovaitseva.   

Abstract

The psychopathological structure and prognostic significance of mild cognitive impairment syndrome (MCI) were studied in a two-year prospective study of randomized cohorts of elderly subjects whose mental state corresponded to the criteria for MCI. A total of 40 patients aged from 50 to 80 years were studied. Patients underwent clinical history-taking, neuropsychological, psychometric, and genetic investigations (genotyping for ApoE), as well as brain imaging studies. The psychopathological structure and psychometric characteristics of MCI syndrome are presented. Clinical and genetic factors with prognostic significance are identified.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197377     DOI: 10.1007/s11055-008-0018-y

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  11 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

Review 2.  Aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  R C Petersen
Journal:  Neurol Clin       Date:  2000-11       Impact factor: 3.806

3.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

4.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

5.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].

Authors:  G I Korovaĭtseva; T V Shcherbatykh; N V Selezneva; S I Gavrilova; V E Golimbet; N I Voskresenskaia; E I Rogaev
Journal:  Genetika       Date:  2001-04

7.  Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R C Petersen; J C Stevens; M Ganguli; E G Tangalos; J L Cummings; S T DeKosky
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

Review 8.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

9.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

10.  Amnestic MCI or prodromal Alzheimer's disease?

Authors:  Bruno Dubois; Martin L Albert
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.